SEC 13F Intelligence

Kestrel Investment Management Corp / IART

Kestrel Investment Management Corp’s Integra Lifesciences Hldgs C Position

Does Kestrel Investment Management Corp own Integra Lifesciences Hldgs C (IART)? Not currently — the last reported position was 99.3K shares worth $2,895 in Q2 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$2,895
Q2 2024
Shares
99.3K
% of Portfolio
+1.92%
Quarters Held
4
position exited

Position History IART

Reported value by quarter
Q3 ’23: $4,676Q3 ’23Q4 ’23: $4,357Q4 ’23Q1 ’24: $3,522Q1 ’24Q2 ’24: $2,895Q2 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202499.3K$2,895+1.92%
Q1 202499.3K$3,522+2.35%
Q4 2023100.0K$4,357+2.95%
Q3 2023122.5K$4,676+2.96%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Kestrel Investment Management Corp’s full portfolio or all institutional holders of IART.